News: EnteroMedics Equity Offering $ETRM
EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 32,000,000 units. Each unit consists of one share of common stock and one Series A warrant to purchase one share of common stock at […]
News: EnteroMedics Equity Offering $ETRM Read More »
